Assessment of Inorganic Phosphate Intake by the Measurement of the Phosphate/Urea Nitrogen Ratio in Urine

Nutrients. 2021 Jan 20;13(2):292. doi: 10.3390/nu13020292.

Abstract

In chronic kidney disease (CKD) patients, it would be desirable to reduce the intake of inorganic phosphate (P) rather than limit the intake of P contained in proteins. Urinary excretion of P should reflect intestinal absorption of P(inorganic plus protein-derived). The aim of the present study is to determine whether the ratio of urinary P to urinary urea nitrogen (P/UUN ratio) helps identify patients with a high intake of inorganic P.A cross-sectional study was performed in 71 patients affected by metabolic syndrome with CKD (stages 2-3) with normal serum P concentration. A 3-day dietary survey was performed to estimate the average daily amount and the source of P ingested. The daily intake ofPwas1086.5 ± 361.3mg/day; 64% contained in animal proteins, 22% in vegetable proteins, and 14% as inorganic P. The total amount of P ingested did not correlate with daily phosphaturia, but it did correlate with the P/UUN ratio (p < 0.018). Patients with the highest tertile of the P/UUN ratio >71.1 mg/g presented more abundant inorganic P intake (p < 0.038).The P/UUN ratio is suggested to be a marker of inorganic P intake. This finding might be useful in clinical practices to identify the source of dietary P and to make personalized dietary recommendations directed to reduce inorganic P intake.

Keywords: CKD; FGF23; PTH; phosphate intake; phosphaturia.

MeSH terms

  • Adult
  • Aged
  • Animals
  • Cross-Sectional Studies
  • Diet*
  • Eating*
  • Female
  • Fibroblast Growth Factor-23
  • Humans
  • Male
  • Middle Aged
  • Phosphates / administration & dosage*
  • Phosphates / urine*
  • Rats
  • Rats, Wistar
  • Urea / urine*

Substances

  • FGF23 protein, human
  • Phosphates
  • Fibroblast Growth Factor-23
  • Urea